ENCORAFENIB for Brain neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 56 adverse event reports in the FDA FAERS database where ENCORAFENIB was used for Brain neoplasm malignant.

Most Reported Side Effects for ENCORAFENIB

Side Effect	Reports	%	Deaths	Hosp.
Death	1,004	11.7%	989	60
Off label use	989	11.6%	165	186
Nausea	758	8.9%	38	213
Fatigue	685	8.0%	54	167
Diarrhoea	574	6.7%	37	221
Neoplasm progression	548	6.4%	163	107
Pyrexia	539	6.3%	34	241
Product use in unapproved indication	506	5.9%	77	63
Vomiting	429	5.0%	24	173
Rash	414	4.8%	22	83
Serous retinal detachment	297	3.5%	13	56
Arthralgia	281	3.3%	13	56
Malaise	266	3.1%	30	85
Decreased appetite	261	3.1%	32	111
Asthenia	213	2.5%	29	85